Approval · Notice of Compliance 27146 · 2021
AYBINTIO: Notice of Compliance 27146
Issued November 20, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27146
- Date
- November 20, 2021
- Company
- Samsung Bioepis Co., LtdIncheon, Incheon, Korea, Republic Of
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- BEVACIZUMAB 100 MG per VIAL
- BEVACIZUMAB 400 MG per VIAL